Wellcome Connecting Science Trafficking Pathways in Neurodegeneration
Wellcome Genome Campus, Hinxton, CB10 1RQ, UK and virtual
Click here to register
Building on links across diverse neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS) and the spastic paraplegias, this conference will provide genetic and functional insights into the underlying etiology of neuronal cell death.
Discussions will centre on neurodegeneration-related human genetics, trafficking dysregulation and challenges of translating mechanistic advances into therapeutics. The programme will highlight cutting-edge techniques, including the use of large-scale data sets and various ’omics’ approaches.
The conference will bring together clinicians specialising in neurology, along with researchers from academia and industry involved in neurodegeneration across the spectrum of human genetics, fundamental cell biology and drug development.
The programme will include short oral presentations selected from abstracts, lightning talks, posters and networking opportunities for a highly interactive meeting.
Deadline for submissions: 04 July 2023
Wellcome Connecting Science
Richard Youle- National Institue of Neurologial Disorders and Stroke, NIH, USA
Chiara Zurzolo- Institut Pasteur, France
Ivan Dikic – Goethe University, Germany
Alexandra Durr – Paris Brain Institute| ICM, France
Henne Holstege – Amsterdam UMC | Vrije Universiteit Amsterdam, Netherlands
Guida Landoure – University of Bamako Bamako, Mali
Frances Platt – University of Oxford, UK
Anna Simonsen – University of Oslo, Norway
Peter St George-Hyslop – University of Cambridge, UK
Jay Xiaojun Tan – University of Pittsburgh, USA
Enza Marie Valente – University of Pavia, Italy
Suzanne Wegmann – DZNE Berlin, Germany
Chris Wheelan – Janssen, USA